Literature DB >> 15356010

Aldosterone to Renin ratio in a primary care setting: the Bussolengo study.

Oliviero Olivieri1, Alberto Ciacciarelli, Denise Signorelli, Francesca Pizzolo, Patrizia Guarini, Chiara Pavan, Angela Corgnati, Salvatore Falcone, Roberto Corrocher, Alessio Micchi, Chiara Cressoni, Gianstefano Blengio.   

Abstract

The aim of the study was to evaluate the prevalence of hypertension associated with an elevated aldosterone to renin activity ratio (ARR) in a sample of adults aged 35-74 yr, randomly selected from the population register of the Bussolengo Health District (northern Italy) and representative of the total population of the district. Subjects (n = 1462) were randomly selected from the population register and examined by their general practitioners. Complete data for 1348 individuals were available for final statistical analysis. Apart from verapamil or alpha-blockers, no hypotensive drugs were allowed during the 4 wk before assay. Direct active renin and aldosterone were measured in the plasma of hypertensive patients after 2 h in the upright posture. Of 412 identified hypertensive patients, 287 subjects agreed to give blood (70% response rate). An aldosterone to active renin ratio (AARR) of 32 pg/ml was taken as the cut-off value, equivalent to an ARR of 50 ng/dl/ng/ml.h. An elevated AARR was observed in 32.4% of the hypertensive patients, with increased prevalence in females and in people aged 55 yr or older. As an elevated AARR is frequent in the general hypertensive population, screening should not be limited to the patients referred to specialist units.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15356010     DOI: 10.1210/jc.2003-032179

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone-renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design.

Authors:  Giacomo Rossitto; Maurizio Cesari; Giulio Ceolotto; Giuseppe Maiolino; Teresa Maria Seccia; Gian Paolo Rossi
Journal:  J Hum Hypertens       Date:  2018-12-05       Impact factor: 3.012

Review 2.  Diagnosis and treatment of primary aldosteronism.

Authors:  Paolo Mulatero; Silvia Monticone; Franco Veglio
Journal:  Rev Endocr Metab Disord       Date:  2011-03       Impact factor: 6.514

3.  Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups.

Authors:  Guoshu Yin; Shaoling Zhang; Li Yan; Muchao Wu; Mingtong Xu; Feng Li; Hua Cheng
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

4.  Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.

Authors:  Wei-Guo Chen; Ting-Ting Zhou; Peng Zhou; Xiao-Wei Li; Zhun Wu; Kai-Yan Zhang; Jin-Chun Xing
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

5.  Kininogen gene (KNG) variation has a consistent effect on aldosterone response to antihypertensive drug therapy: the GERA study.

Authors:  Maja Barbalic; Gary L Schwartz; Arlene B Chapman; Stephen T Turner; Eric Boerwinkle
Journal:  Physiol Genomics       Date:  2009-07-07       Impact factor: 3.107

6.  Potential effects of age on screening for primary aldosteronism.

Authors:  Q Luo; N F Li; X G Yao; D L Zhang; S F Y Abulikemu; G J Chang; K M Zhou; G L Wang; M H Wang; W J Ouyang; Q Y Cheng; Y Jia
Journal:  J Hum Hypertens       Date:  2015-04-16       Impact factor: 3.012

7.  The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua).

Authors:  Maurizio Cesari; Giulio Ceolotto; Giacomo Rossitto; Giuseppe Maiolino; Teresa Maria Seccia; Gian Paolo Rossi
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-03-16

Review 8.  A comprehensive review of the clinical aspects of primary aldosteronism.

Authors:  Gian Paolo Rossi
Journal:  Nat Rev Endocrinol       Date:  2011-05-24       Impact factor: 43.330

9.  Analysis of various etiologies of hypertension in patients hospitalized in the endocrinology division.

Authors:  Dan Ye; FengQin Dong; XunLiang Lu; Zhe Zhang; YunFei Feng; ChengJiang Li
Journal:  Endocrine       Date:  2012-01-03       Impact factor: 3.633

10.  Prognostic value of semiquantification NP-59 SPECT/CT in primary aldosteronism patients after adrenalectomy.

Authors:  Ching-Chu Lu; Vin-Cent Wu; Kwan-Dun Wu; Kao-Lang Liu; Wei-Chou Lin; Mei-Fang Cheng; Kai-Yuan Tzen; Ruoh-Fang Yen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-14       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.